Mucocutaneous Leishmaniasis Associated With Anti-TNF Therapy: A Case Report

Author(s):  
T Valdés Delgado ◽  
C Rodríguez Delgado ◽  
M Pérez-Pérez
Author(s):  
Sheridan Joseph ◽  
Timothy J. Whitman ◽  
Frederick S. Buckner ◽  
Anna L. Cogen

Cutaneous leishmaniasis (CL) is often caused by Leishmania braziliensis (L. braziliensis) in South America. Because of the risk for mucocutaneous leishmaniasis, L. braziliensis is frequently treated with parenteral or oral medications. Here, we present a case of a young woman with L. braziliensis (CL) that did not respond to miltefosine but eventually experienced spontaneous resolution. This case highlights the potential for treatment failure and the importance of clinical monitoring in the setting of cutaneous leishmaniasis caused by L. braziliensis.


Author(s):  
Jaime A. Soto ◽  
María Isabel Méndez ◽  
Jonathan D. Berman

We present case reports of two patients treated with miltefosine for mucocutaneous leishmaniasis whose gastrointestinal symptoms were initially diagnosed as a drug reaction and only later recognized as due to COVID-19. Gastrointestinal symptoms of COVID-19 are unusual, whereas gastrointestinal adverse drug reactions are very common. These reports exemplify that this infrequent presentation of COVID-19 is likely to be ascribed to a more common etiology such as a gastrointestinal drug reaction.


2014 ◽  
Vol 10 (4) ◽  
pp. 167-173
Author(s):  
Manuel Antonio Gordón-Núñez ◽  
Stefânia Jeronimo Ferreira ◽  
Ana Luiza Dias Leite de Andrade ◽  
Kléber Giovanni Luz ◽  
Eveline Pipolo Milan ◽  
...  

2020 ◽  
Vol 3 (3) ◽  
pp. 73-78
Author(s):  
A.A. Schenck ◽  
A.C. Westgeest ◽  
E.J.C. Teunissen ◽  
E.F. Schippers ◽  
J.P. Koopman

Author(s):  
Juan Echevarría ◽  
Pablo Campos ◽  
Jaime Chang ◽  
Luis Cuéllar ◽  
Eduardo Gotuzzo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document